201 related articles for article (PubMed ID: 31221721)
1. Systems-level Analysis Reveals Multiple Modulators of Epithelial-mesenchymal Transition and Identifies DNAJB4 and CD81 as Novel Metastasis Inducers in Breast Cancer.
Uretmen Kagiali ZC; Sanal E; Karayel Ö; Polat AN; Saatci Ö; Ersan PG; Trappe K; Renard BY; Önder TT; Tuncbag N; Şahin Ö; Ozlu N
Mol Cell Proteomics; 2019 Sep; 18(9):1756-1771. PubMed ID: 31221721
[TBL] [Abstract][Full Text] [Related]
2. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
5. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
[TBL] [Abstract][Full Text] [Related]
6. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
7. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
Matsunuma R; Chan DW; Kim BJ; Singh P; Han A; Saltzman AB; Cheng C; Lei JT; Wang J; Roberto da Silva L; Sahin E; Leng M; Fan C; Perou CM; Malovannaya A; Ellis MJ
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11978-E11987. PubMed ID: 30498031
[TBL] [Abstract][Full Text] [Related]
8. The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis.
Keinan O; Kedan A; Gavert N; Selitrennik M; Kim S; Karn T; Becker S; Lev S
J Cell Sci; 2014 Nov; 127(Pt 21):4740-9. PubMed ID: 25179602
[TBL] [Abstract][Full Text] [Related]
9. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
10. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
11. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
12. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
[TBL] [Abstract][Full Text] [Related]
13. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
[TBL] [Abstract][Full Text] [Related]
14. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.
Davis FM; Azimi I; Faville RA; Peters AA; Jalink K; Putney JW; Goodhill GJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Oncogene; 2014 May; 33(18):2307-16. PubMed ID: 23686305
[TBL] [Abstract][Full Text] [Related]
15. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
16. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
[TBL] [Abstract][Full Text] [Related]
17. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.
Vuoriluoto K; Haugen H; Kiviluoto S; Mpindi JP; Nevo J; Gjerdrum C; Tiron C; Lorens JB; Ivaska J
Oncogene; 2011 Mar; 30(12):1436-48. PubMed ID: 21057535
[TBL] [Abstract][Full Text] [Related]
18. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
[TBL] [Abstract][Full Text] [Related]
19. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
[TBL] [Abstract][Full Text] [Related]
20. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.
Chakrabarti R; Hwang J; Andres Blanco M; Wei Y; Lukačišin M; Romano RA; Smalley K; Liu S; Yang Q; Ibrahim T; Mercatali L; Amadori D; Haffty BG; Sinha S; Kang Y
Nat Cell Biol; 2012 Nov; 14(11):1212-22. PubMed ID: 23086238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
